German drugmaker earns FDA warning; Pfizer facility wins environmental recognition;

> Another non-U.S. drug manufacturer--Jenahexal Pharm in Germany--has been stung with an FDA warning as the regulator continues its ex-U.S. inspection blitz. Warning Letter

> Pfizer's ($PFE) Montreal manufacturing plant has won an innovation award for an environmentally friendly cleaning process. Pfizer release

> Pfizer's ($PFE) Loughbeg, Ireland, plant conforms to the ISO 50001 standard for improving building energy performance, which emphasizes improvements in energy efficiency, use and consumption. More

> U.K.-based Shire ($SHPGY) has filed for regulatory approval to produce its Gaucher disease drug, VPRIV, at its facility in Lexington, MA, freeing capacity at its Cambridge, MA, plant for Fabry disease treatment Replagal--both competitors of drugs from nearby Genzyme. Story

> Three Aurobindo Pharma workers sustained burns in a reactor explosion at an API plant in India.  News

> While "optimizing" its contracts with wholesalers, Novartis ($NVS) has halted deliveries to some in a pricing dispute. Report | Item

> Former KV Pharmaceutical ($KV.A) VP Melissa Hughes is suing the drugmaker, saying the company interfered with her stock options. Report

> Label maker ATL has signed a deal with Document Security Systems for use of the latter's AuthentiGuard technology in anti-counterfeiting labels. Story

> The Hong Kong Department of Health has directed APT Pharma to recall a batch of diabetes treatment Glupozide after a plastic fragment was found embedded in a tablet. Announcement

Suggested Articles

Transporting pharmaceutical products at <-60C for more than 96 hours has seemed an insurmountable challenge. TOWER’s solution has solved the problem.

Roche will spend $500 million for a new global manufacturing logistics hub in Canada that will eventually employ 500 workers in Ontario.

Fledgling Indiana CDMO Incog BioPharma Services is shelling out $60 million to get its first manufacturing facility off the ground.